Meta-analysis of prognostic value of inflammation parameter in breast cancer.

Jie Chen,Yuqin Pan,Bangshun He,Houqun Ying,Huiling Sun,Qiwen Deng,Xian Liu,Shukui Wang

DOI: https://doi.org/10.4103/0973-1482.160917

2018-01-01

Journal of Cancer Research and Therapeutics

Abstract:CONTEXT:Recently, increasing studies investigated the association between inflammation parameter such as neutrophil to lymphocyte ratio (NLR) and the prognosis of cancers. However, the clinical and prognostic significance of NLR in breast cancer remains controversial. AIM:This meta-analysis was conducted to establish the overall accuracy of the NLR test in the diagnosis of breast cancer. MATERIALS AND METHODS:A comprehensive search of the literature was conducted using PubMed and Web of Science. Six studies dating up to July 2014 with 2267 patients were enrolled in the present study. STATA 11.0 software (STATA Corporation, College Station, TX, USA) was selected for data analysis. In order to evaluate the association between NLR and overall survival (OS), disease-free survival (DFS), recurrence-free survival or cancer-specific survival, the hazard ratios (HRs), and their 95% confidence intervals (CIs) were extracted. RESULTS:Subgroup analyses showed that NLR was a strong prognostic factor for OS in multivariate analysis (HR = 2.81, 95% CI = 2.13-3.71, PH = 0.992) and without metastasis (HR = 1.45, 95% CI = 0.37-5.66, PH < 0.001). Elevated NLR was associated with a high risk for DFS in subgroups of multivariate analysis (HR = 2.16, 95% CI = 1.67-2.80, PH = 0.977) and mixed metastasis (HR = 2.13, 95% CI = 1.38-3.30, PH = 0.84). CONCLUSION:In summary, NLR may be considered as a predictive factor for patients with breast cancer.